News
OPGN
0.6300
+2.26%
0.0139
OpGen Inc Announces David Lazar as New CEO
TipRanks · 2d ago
OPGEN - ON APRIL 11 ENTERED EMPLOYMENT AGREEMENT WITH DAVID LAZAR POST WHICH LAZAR WILL ACT AS CO'S CHIEF EXECUTIVE OFFICER
Reuters · 2d ago
Weekly Report: what happened at OPGN last week (0408-0412)?
Weekly Report · 4d ago
Weekly Report: what happened at OPGN last week (0401-0405)?
Weekly Report · 04/08 09:56
12 Health Care Stocks Moving In Monday's After-Market Session
OpGen (NASDAQ:OPGN) shares moved upwards by 24.0% to $0.74 during Monday's after-market session. Kyverna Therapeutics shares increased by 9.19%. Galecto and Ontrak also gained ground. Gritstone Bio and Aclarion were among the losers in the market.
Benzinga · 04/01 20:31
OpGen 13D Filing Shows David E. Lazar Reported A 19.9% Stake In The Co As Of March 25, 2024
Benzinga · 04/01 20:12
DAVID E. LAZAR REPORTS 19.9% STAKE IN OPGEN INC AS OF MARCH 25- SEC FILING
Reuters · 04/01 20:09
DAVID E. LAZAR - PURCHASED OPGEN INC'S SHARES BASED ON BELIEF THAT THE SHARES, WHEN PURCHASED, WERE UNDERVALUED
Reuters · 04/01 20:09
Weekly Report: what happened at OPGN last week (0325-0329)?
Weekly Report · 04/01 09:56
OpGen Inc Secures $3M Investment, Enhances Corporate Structure
OpGen, Inc. Has struck a deal with investor David E. Lazar to purchase 3 million shares of Series E Convertible Preferred Stock for $3 million. The deal aims to alleviate the company's debt and support general corporate needs. OPGN stock is down 2.7% in the last week.
TipRanks · 03/29 18:52
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 67.2% to $3.77 during Wednesday's pre-market session. The company's, Q4 earnings came out today. NovoCure stock rose 17.9% and Nutriband shares rose 24.34% in the same session. Akili stock decreased by 20.6% and OpGen stock fell 15.67% during the session.
Benzinga · 03/27 13:05
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates
U.S. Stocks traded higher toward the end of trading on Tuesday, with the Dow Jones gaining over 80 points. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23%. TD SYNNEX Corporation reported better-than-expected first-quarter earnings. Consumer discretionary shares jumped by 0.6% on Monday. Asian markets closed mixed while European shares were higher today.
Benzinga · 03/26 19:08
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Westport Fuel Systems Inc. (NASDAQ:WPRT) posts wider-than-expected fourth-quarter loss. Krispy Kreme, Inc. And McDonald's expanded their partnership. Stoke Therapeutics, Inc., shares gained 72.6% to $11.24. C3is Inc. Reported a year-over-year increase in financial results.
Benzinga · 03/26 17:45
12 Health Care Stocks Moving In Tuesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's, Q4 earnings came out 3 days ago. Mesoblast and OpGen shares also moved upwards.
Benzinga · 03/26 17:31
Dow Gains 100 Points; McCormick Posts Upbeat Results
U.S. Stocks traded higher midway through trading on Tuesday, with the Dow Jones gaining around 100 points. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27%. McCormick & Co Inc reported better-than-expected first-quarter financial results. Consumer discretionary shares jumped by 0.8% on Monday. Asian markets closed mixed on Tuesday.
Benzinga · 03/26 16:08
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% on Tuesday. U.S. Durable goods orders increased by 1.4% month-over-month in February. Consumer discretionary shares jumped by 0.7% on Monday. Asian markets closed mixed in Asia Pacific markets.
Benzinga · 03/26 14:09
Why Is Penny Stock OpGen Trading Higher On Tuesday?
OpGen Inc (NASDAQ:OPGN) shares are trading higher on a strong session volume of 1.42 million. The company entered into a securities purchase agreement with a private investor to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for $3.0 million.
Benzinga · 03/26 13:52
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners , Alibaba, McCormick
U.S. Stock index futures ticked up on Tuesday as most megacap and chip stocks advanced. Investors readied for more data to assess the Federal Reserve's rate path. Dow e-minis were up 0.10% at 39,739.25. The top three NYSE percentage gainers were Reddit, Alibaba and McCormick.
Reuters · 03/26 13:16
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The company's, Q4 earnings came out yesterday. OpGen shares moved upwards by 77.6% and Praxis Precision Medicine (PRAX) shares increased by 21.38%. ABVC BioPharma (ABVC) and Sutro Biopharma (STRO) were among the losers.
Benzinga · 03/26 13:05
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Shares of Stoke Therapeutics, Inc. Rose sharply in today's pre-market trading. The company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Check-Cap Ltd. Shares gained 38.3% to $2.67 in pre- market trading. Krispy Kreme and McDonald's USA announced expanded national partnership.
Benzinga · 03/26 12:00
More
Webull provides a variety of real-time OPGN stock news. You can receive the latest news about Opgen through multiple platforms. This information may help you make smarter investment decisions.
About OPGN
OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.